Life Science News

Latest updates from the biotech and pharma world

Endpoints News 2026-01-21

Tanabe pill delays blood disorder; enGene adds up to $100M from loans

Endpoints News 2026-01-21

IntraBio says rare disease drug passes Phase 3, will seek FDA approval

Endpoints News 2026-01-21

#JPM26: Regeneron, Lilly, Summit on rivals crowding into same targets

Endpoints News 2026-01-21

Exclusive: Claim Health raises $4.4M to help home care providers get paid

Endpoints News 2026-01-21

Fosun-funded Hygtia Therapeutics licenses Insilico’s NLRP3 inhibitor for Parkinson’s

Endpoints News 2026-01-21

Think Bioscience gets $55M to unearth new drug pockets

Endpoints News 2026-01-20

Government funding bill features PBM reforms, voucher reauthorization

Endpoints News 2026-01-20

EU Parliament adopts stricter drug stockpiling rules under Critical Medicines Act

Endpoints News 2026-01-20

Valneva withdraws chikungunya vaccine from US

Endpoints News 2026-01-20

Clinician groups ask court to overturn CDC's childhood vaccine overhaul

Endpoints News 2026-01-20

Aspect Bio takes Novo castoff therapies; Takeda trims US jobs

Endpoints News 2026-01-20

Teladoc’s mental health arm BetterHelp has quietly expanded the use of AI

Endpoints News 2026-01-20

2025 ended on high note with a buoyant Q4 for M&A, PIPEs and follow-ons

Endpoints News 2026-01-20

Pfizer to depart GSK's ViiV as Shionogi doubles its stake

Endpoints News 2026-01-20

J&J, Isomorphic sign research deal for AI-made molecules

Endpoints News 2026-01-20

GSK makes $2.2B deal for RAPT and its food allergy candidate

Endpoints News 2026-01-20

Exciva raises $59M Series B to fund Phase 2 test of Alzheimer’s agitation drug

Endpoints News 2026-01-17

JPM recap; Mirador raises $250M; Genentech’s PBM shift; and more

Endpoints News 2026-01-16

Agomab and SpyGlass file for IPOs as investor enthusiasm builds after JPM

Endpoints News 2026-01-16

AbbVie, Genmab say Epkinly didn't prolong overall survival in lymphoma study

18 / 39